Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.

Diagnostic Microbiology and Infectious Disease

Volumn 32, Issue 1, 1998, Pages 33-37

  Marco, F ^a,b   Pfaller, Michael A ^a   Messer, S A ^a   Jones, R N ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BLOOD; CANDIDA; FLUCONAZOLE; FLUCYTOSINE; HUMANS; ITRACONAZOLE; PEPTIDES; PEPTIDES, CYCLIC; SENSITIVITY AND SPECIFICITY; SERUM BACTERICIDAL TEST;

EID: 0032422450     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00050-9     Document Type: Article

References (17)

1. Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Krupa D, Pikounis VB, Kropp H, Bartizal K (1995) Evaluation of water-soluble pneumocandin analogs L-733560, L-705589 and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother 39:1077-1081.
2. Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Pikounis VB, Kropp H, Bartizal K (1997) Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother 41:2333-2338.
3. Bartizal K, Gill CJ, Abruzzo GK, Flattery AM, Kong L, Scott PM (1997) In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother 41:2326-2332.
4. Bartizal K, Scott T, Abruzzo GK, Gill CJ, Pacholok C, Lynch L, Kropp H (1995) In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob Agents Chemother 39:1070-1076.
5. Debono M, Gordee RS (1994) Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol 48:471-497.
6. del Poeta M, Schell WA, Perfect JR (1996) In vitro antifungal activity of L-743,872 against a variety of clinically important moulds. Antimicrob Agents Chemother 41:1835-1836.
7. Espinel-Ingroff A (1996) In vitro studies with L-743,872, a water soluble pneumocandin: a comparative study (Abstr. F31). Programs and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Washington, DC: American Society for Microbiology, p. 105.
8. Franzot SP, Casadevall A (1997) Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro. Antimicrob Agents Chemother 41:331-336.
9. Graybill JR, Najvar LK, Luther MF, Fothergill AW (1997) Treatment of murine disseminated candidiasis with L-743,872. Antimicrob Agents Chemother 41:1775-1777.
10. Graybill JR, Najvar LK, Montalbo EM, Barchiesi FJ, Luther MF, Rinaldi MG (1998) Treatment of histoplasmosis with MK-991 (L-743,872). Antimicrob Agents Chemother 42:151-153.
11. Kurtz MB, Douglas C, Marrinan J, Nollstadt K, Onishi J, Dreikorn S, Milligan J, Mandala S, Thompson J, Balkovec JM (1994) Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob Agents Chemother 38:2750-2757.
12. National Committee for Clinical Laboratory Standards (NCCLS) (1997) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast: Approved Standard M27-A. Wayne, PA: NCCLS.
13. Nelson PW, Lozano-Chiu M, Rex JH (1997) In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin-B and fluconazole-resistant Candida isolates: influence of assay conditions. J Med Vet Mycol 35:285-287.
14. Pfaller MA, Messer SA, Coffman S (1997) In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. Antimicrob Agents Chemother 41:763-766.
15. Powles MA, Anderson J, Liberator P, Schmatz DM (1996) Efficacy of semisynthetic pneumocandin analog L-743,872 against Pneumocystis carinii in murine models (Abstr. F42). Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Washington, DC: American Society for Microbiology, p. 107.
16. Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL (1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 24:235-247.
17. Vazquez JA, Lynch M, Boikov D, Sobel JD (1997) In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species. Antimicrob Agents Chemother 41:1612-1614.